welbournes

National Patient Safety Alert: Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets. National Patient Safety Alert Reference Number: NatPSA/2023/011/DHSC Date issued: 27th September 2023 Brief description of the problem There are supply disruptions affecting various strengths of the following medications which are licensed for the treatment of attention deficit hyperactivity [...]

The post National Patient Safety Alert: Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets. appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 2 September 2023) has been published and includes articles on: Statins: very infrequent reports of myasthenia gravis Fluoroquinolone antibiotics: suicidal thoughts and behaviour Letters and medicine recalls sent to healthcare professionals in August 2023. To see the latest MHRA Drug [...]

The post MHRA Drug Safety Update: September 2023 appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for the Somatropin (Genotropin® MiniQuick) 0.6mg and 1.4mg powder and solvent for solution for injection pre-filled disposable devices. Somatropin (Genotropin® GoQuick) 5.3mg powder and solvent for solution for injection pre-filled, multi-dose pens MSN/2023/089 Tier 2 – medium impact Date of issue 21st [...]

The post Medicine Supply Notification: Somatropin (Genotropin® MiniQuick) 0.6mg, 1.4mg and (Genotropin® GoQuick) 5.3mg powder and solvent for solution for injection pre-filled disposable devices – Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for the Discontinuation of lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices MSN/2023/088 Tier 2 – medium impact Date of issue 21st September 2023 Lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices are being discontinued and stock will [...]

The post Medicine Supply Notification: Discontinuation of lixisenatide (Lyxumia® ) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Hyoscine hydrobromide (Scopoderm®) 1.5mg patches. MSN/2023/087 Tier 2 – medium impact Date of issue 21st September 2023 Hyoscine hydrobromide (Scopoderm®) 1.5mg patches are in limited supply until w/c 1st January 2024. Alternative formulations of hyoscine hydrobromide remain available and will be [...]

The post Medicine Supply Notification: Hyoscine hydrobromide (Scopoderm® ) 1.5mg patches appeared first on Community Pharmacy England.